Falls, physical performance deficits, and functional losses in cancer survivors with chemotherapy-induced neuropathy (CIPN): A University of Rochester CCOP study.
Supriya G. Mohile(University of Rochester Medical Center), Gary R. Morrow(University of Rochester Medical Center), Karen M. Mustian(University of Rochester Medical Center), Charles E. Heckler(University of Rochester Medicine), Jennifer S. Gewandter(University of Rochester), Shaker R. Dakhil(Cancer Center of Kansas), Luke J. Peppone(University of Rochester Medical Center), J. Martin Miller(Metro-Minnesota Community Oncology Research Consortium), Judith O. Hopkins(Novant Health)
Cited by 0
Related Papers
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
|Journal of Clinical Oncology|1999|670
Prevalence, Demographics, and Psychological Associations of Sleep Disruption in Patients With Cancer: University of Rochester Cancer Center–Community Clinical Oncology Program
|Journal of Clinical Oncology|2009|564
Oxaliplatin, Fluorouracil, and Leucovorin for Patients With Unresectable Liver-Only Metastases From Colorectal Cancer: A North Central Cancer Treatment Group Phase II Study
|Journal of Clinical Oncology|2005|541
Applied Discriminant Analysis
|Technometrics|1995|409